Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection. - Herrera AL; Van Hove C; Hanson M; Dale JB; Tweten RK; Huber VC; Diel D; Chaussee MS (PloS one, 2020)